IFNG and neoplasm: Using either T cell-deficient nude mice, mice depleted of CD8 T cells as well as mice receiving IFNγ neutralizing antibodies, we identified IFNγ-secreting CD8 T cells as a major driver of PD-L1 tumor expression in vivo following Folfox treatment.